2021

• Ratziu V, de Guevara L, Safadi R, Poordad F, Fuster F, Flores-Figueroa J, Arrese M, Fracanzani AL, Ben Bashat D, Lackner K, Gorfine T, Kadosh S, Oren R, Halperin M, Hayardeny L, Loomba R, Friedman S. Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial. Nat Med 2021; 27(10): 1825-35.
• Aguirre García, M. M., Mancilla-Galindo, J., Paredes-Paredes, M., Tiburcio, A. Z. & Ávila Vanzzini, N. Mechanisms of infection by SARS-CoV-2, inflammation and potential links with the microbiome. Future Virology 16(1), 43–57 (2021).

2020

• Ojeda J, Arredondo JL, Salcedo P, Paredes-Paredes M, Dupuy M, Petit C, Chabanon AL, Rivas E, Gurunathan S, De Bruijn I, Pepin S. Immunogenicity and safety of a multi-dose quadrivalent inactivated influenza vaccine in individuals aged 6 months to 17 years: a randomized phase III trial. Hum Vaccin Immunother. 2020 Jun 2;16(6):1380-1384.

2018

• Flores-Figueroa Jose, Badillo Ingrid, Botello Gilberto, Pacheco Ursus, Paredes Paredes Mercedes, McGoven Suzan. Remuneration in the United States and Mexico: Assessing the level of influence on potential clinical research participants about their decision to participate in a clinical trial and the risk of fraud. Clinical Ethics 2018 Jan 13 (2).

2017

• Flores Figueroa J, Morales Cerda JD, Belalcazar Lopez VM, Zuqui Ramirez MA. Efficacy and safety of tolperisone 50mg and paracetamol 300mg. Phase IV clinical study. Rev Latinoam Cir Ortop 2017; 2: 2.
• Stevens, Esposito, Stoney, Hamer, Flores-Figueroa, Bottieau, Connor, Gkrania-Klotsas, Goorhuis, Hynes, Libman, Lopez-Velez, McCarthy, Sonnenburg, Schwartz, van Genderen, Benson and Leung. Clostridium difficile-associated diarrhea in returning travelers. J Trav Med 2017; 1-6.
• Flores-Figueroa Jose, Ortiz Navarrete Vianney, Paredes Paredes Mercedes, Espinosa López Fernando Rogelio, Castro D´Franchis Luis Javier Urinary IL-8 as an Early Diagnostic Tool for Nosocomial Urinary Tract Infection. Medical Science and Technology 2017 May 58(7): 15-20

2016

• Barrera C, Mykietiuk A, Metev H, Floarea Nitu M, Karimjee N, Doreski A, Mitha I, Tanaseanu CM, Molina JM, Antonovsky Y, Van Rensburg DJ, Rowe BH, Flores-Figueroa J, Sokolowska B, Clark K, Keedy K, Sheets A, Scott D, Das A, Jamieson B, Fernandes P and Oldach D. SOLITAIRE-ORAL: A Randomized, Double-Blind, Multi-Center, Global Phase 3 Study Comparing the Efficacy and Safety of Oral Solithromycin to Oral Moxifloxacin for Treatment of Community Acquired Bacterial Pneumonia (CABP). Lancet Infect Dis 2016; 16: 421-30.

2014

• Nair P, Okhuysen PC, Jiang ZD, Carlin LG, Belkind-Gerson J, Flores J, Paredes M, DuPont HL. Persistent abdominal symptoms in US adults after short-term stay in Mexico. J Travel Med. 2014 May-Jun;21(3):153-8

2013

• Behrens RH, Cramer JP, Jelinek T, Shaw H, von Sonnenburg F, Wilbraham D, Weinke T, Bell DJ, Asturias E, Pauwells HL, Maxwell R, Paredes-Paredes M, Glenn GM, Dewasthaly S, Stablein DM, Jiang ZD, Dupont HL. Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers’ diarrhoea: a phase 3, randomized, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala. Lancet Infect Dis. 2013 Nov 28. PubMed PMID: 24291168.

2011

• Flores-Figueroa J, Okhuysen PC, von Sonnenburg F, DuPont HL, Libman MD, Keystone JS, Hale DC, Burchard G, Han PV, Wilder-Smith A, Freedman DO for the GeoSentinel Survbeillance Network. Patterns of Illness in Travelers Visiting Mexico and Central America: The GeoSentinel Experience. Clin Infect Dis 2011; 53: 523-31.
• Mohamed JA, DuPont HL, Flores J, Palur H, Nair P, Jiang ZD, Guo D, Belkind-Gerson J and Okhuysen PC. Single nucleotide polymorphisms in the promoter of the gene encoding the lipopolysaccharide receptor CD14 are associated with and increased risk for bacterial diarrhea in North American travelers to Mexico. Clin Infect Dis 2011; 52: 1332-41.
• Paredes-Paredes M, Flores-Figueroa J, and DuPont HL. Advances in the Treatment of Travelers’ Diarrhea. Curr Gastroenterol Rep 2011; 13: 402-7.
• Flores J, DuPont HL, Jiang ZD, Okhuysen PC, Melendez-Romero JH, Gonzalez-Estrada A, Carrillo I and Paredes M. A Randomized, Double-Blind, Study of Rifaximin 550mg vs. Placebo in the Prevention of Travelers’ Diarrhea in Mexico during the Dry Seasons. J Travel Med 2011; 18:333-6.
• Villa N, Okhuysen P, Flores-Figueroa J, Paredes M, Jiang ZD, Belkind-Gerson J, Mohamed J, Nair P, Carlin L and DuPont H. Campylobacter jejuni is Not an Important Pathogen as a Cause of Travelers’ Diarrhea in U.S. Travelers to Mexico. J Travel Med 2011; 18: 56-8.
• Paredes-Paredes M, Okhuysen PC, Flores J, Mohamed JA, Padda RS, Gonzalez-Estrada A, Haley CA, Carlin LG, Nair P and DuPont HL. Seasonality of Diarrheagenic Eschericha coli pathotypes in U.S. Students Acquiring Diarrhea in Mexico. J Travel Med 2011; 18: 121-5.

2010

• Ouyang-Latimer J, Ajami NJ, Jiang ZD, Okhuysen PC, Paredes M, Flores J and Dupont HL. Biochemical and Genetic Diversity of Enterotoxigenic Escherichia coli Associated with Diarrhea in United States Students in Cuernavaca and Guadalajara, Mexico, 2004-2007. J Infect Dis 2010; 201: 1831-8.
• Flores J, DuPont HL, Paredes-Paredes M, Aguirre-Garcia MM, Rojas A, Gonzalez A and Okhuysen PC. Whole Blood Interferon Gamma (IFN-alpha) Response to Cholera Toxin B Subunit and Resistance to Travelers’ Diarrhea. A Pilot Study of Cellular Immune Response in Enterotoxigenic Escherichia coli Associated Diarrhea. Clin Vac Imm 2010; 17: 879-81.
• Ajami NJ, Koo HL, Darkoh C, Atmar RL, Okhuysen PC, Jiang ZD, Flores J and DuPont HL. Characterization of Norovirus-associated Travelers’ Diarrhea. Clin Infect Dis 2010; 51: 123-30.

2009

• Flores J and Okhuysen PC. Genetics of Susceptibility to Infection with Enteric Pathogens. Curr Opin Infect Dis 2009; 22: 471-6.
• Mohamed JA, Dupont HL, Jiang ZD, Flores J, Carlin LG, Belkind-Gerson J, Martinez-Sandoval FG, Guo D, White Jr AC and Okhuysen PC. A Single-Nucleotide Polymorphism in the Gene Encoding Osteoprotegerin, an Anti-inflammatory Protein Produced in Response to Infection with Diarrheagenic Escherichia coli, Is Associated with an Increased Risk of Nonsecretory Bacterial Diarrhea in North American Travelers to Mexico. J Infect Dis 2009; 199: 477-85.
• Flores J and Okhuysen PC. Enteroaggregative Escherichia coli Infection. Curr Opin Gastroenterol 2009; 25: 8-11.

2008

• Nair P, Mohamed JA, DuPont HL, Figueroa JF, Carlin LG, Jiang ZD, Belkind-Gerson J, Martinez- Sandoval FG and Okhuysen PC. Epidemiology of Cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg 2008; 72: 210-4.
• Flores J, DuPont HL, Lee SA, Belkind-Gerson J, Paredes M, Mohamed JA, Armitige LY, Guo DC and Okhuysen PC. Influence of Host Interleukin-10 Polymorphisms on Development of Traveler’s Diarrhea Due to Heat-Labile Enterotoxin-Producing Escherichia coli in Travelers from the United States Who Are Visiting Mexico. Clin Vac Imm 2008; 15: 1194-8.
• Flores J, DuPont HL, Jiang ZD, Belkind-Gerson J, Mohamed JA, Carlin LG, Padda RS, Paredes M, Martinez-Sandoval JF, Villa NA and Okhuysen PC. Enterotoxigenic Escherichia coli Heat-Labile Toxin Seroconversion in US travelers to Mexico. J Travel Med 2008; 3: 156-61.
• Grimes KA, Mohamed JA, DuPont HL, Padda RS, Jiang ZD, Flores J, Belkind-Gerson J, Martinez- Sandoval FG and Okhuysen PC. A PCR Based Assay for the Detection of Diarrheagenic Escherichia coli from Occult Blood Detection Cards in U.S. Travelers to Mexico with Acute Diarrhea. J Clin Microbiol 2008; 46: 2227-30.
• Frech SA, DuPont HL, Bourgeois AL, McKenzie R, Belkind-Gerson J, Figueroa JF, Okhuysen PC, Guerrero NH, Martinez-Sandoval FG, Melendez-Romero JHM, Jiang ZD, Asturias EJ, Halpern J, Torres OR, Hoffman AS, Villar CP, Kassem RN, Flyer DC, Andersen BH, Kazempour K, Breisch SA and Glenn GM. Protection against Travelers’ Diarrhea in a Randomized, Double-blind, Placebo- Controlled Field Trial of a Patch Containing Heat-Labile Toxin from Escherichia coli. Lancet 2008; 371:2019-2025.
• Huang DB, Brown EL, DuPont HL, Cerf J, Carlin L, Flores J, Belkind-Gerson J, Nataro JP and Okhuysen PC. Seroprevalence to the enteroaggregative Escherichia coli virulence factor dispersin among USA travelers to Cuernavaca, Mexico: A Pilot Study. J Med Microbiol. 2008; 57: 476-9.

2007

• Mohamed JA, DuPont HL, Jiang ZD, Belkind-Gerson J, Figueroa JF, Armitige LY, Tsai A, Nair P, Martinez-Sandoval FJ, Guo D, Hayes P and Okhuysen PC. A Novel Single Nucleotide Polymorphism in the Lactoferrin Gene Is Associated with Susceptibility to Diarrhea in North American Travelers to Mexico. Clin Infect Dis 2007; 44: 945-52.

2006

• Castro DFLJ, Espinosa LFG and Flores FJ. [Digestive Bleeding due to Peptic Ulcer Disease Treatment: Omeprazol vs Ranitidine] [Article in Spanish]. Rev Asoc Med Crit Ter Int 2006; 20: 87-92.

2004

• Ramirez HJM and Figueroa JF. [Bispectral monitorization at the Critical Care Unit: clinical application and actual evidences] [Article in Spanish]. Rev Asoc Mex Med Crit Ter Int 2004; 18: 192-8.